CLEANSPARK INC (CLSK)

US18452B2097 - Common Stock

11.14  +0.23 (+2.11%)

After market: 11.2999 +0.16 (+1.44%)

Fundamental Rating

3

Taking everything into account, CLSK scores 3 out of 10 in our fundamental rating. CLSK was compared to 278 industry peers in the Software industry. The financial health of CLSK is average, but there are quite some concerns on its profitability. CLSK has a correct valuation and a medium growth rate.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

CLSK had positive earnings in the past year.
In the past year CLSK has reported a negative cash flow from operations.
CLSK had negative earnings in each of the past 5 years.
CLSK had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

CLSK has a Return On Assets of -10.97%. This is in the lower half of the industry: CLSK underperforms 61.15% of its industry peers.
CLSK has a Return On Equity (-11.55%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -10.97%
ROE -11.55%
ROIC N/A
ROA(3y)-12.54%
ROA(5y)-50.73%
ROE(3y)-13.88%
ROE(5y)-64.36%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 59.45%, CLSK is doing worse than 62.59% of the companies in the same industry.
In the last couple of years the Gross Margin of CLSK has grown nicely.
CLSK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.38%
GM growth 5Y5.92%

More info and screens

6

2. Health

2.1 Basic Checks

CLSK does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for CLSK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

CLSK has an Altman-Z score of 26.24. This indicates that CLSK is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CLSK (26.24) is better than 93.53% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that CLSK is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.00, CLSK is doing good in the industry, outperforming 66.91% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 26.24
ROIC/WACCN/A
WACC11.82%

2.3 Liquidity

A Current Ratio of 8.94 indicates that CLSK has no problem at all paying its short term obligations.
CLSK's Current ratio of 8.94 is amongst the best of the industry. CLSK outperforms 96.40% of its industry peers.
A Quick Ratio of 8.94 indicates that CLSK has no problem at all paying its short term obligations.
CLSK's Quick ratio of 8.94 is amongst the best of the industry. CLSK outperforms 96.40% of its industry peers.
Industry RankSector Rank
Current Ratio 8.94
Quick Ratio 8.94

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 105.30% over the past year.
EPS 1Y (TTM)105.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%69.99%

3.2 Future

CLSK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 145.71% yearly.
Based on estimates for the next years, CLSK will show a very strong growth in Revenue. The Revenue will grow by 21.98% on average per year.
EPS Next Y1215.8%
EPS Next 2Y145.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year96.42%
Revenue Next 2Y37.04%
Revenue Next 3Y21.98%
Revenue Next 5YN/A

3.3 Evolution

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 159.14, which means the current valuation is very expensive for CLSK.
CLSK's Price/Earnings is on the same level as the industry average.
CLSK's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.73.
A Price/Forward Earnings ratio of 12.09 indicates a correct valuation of CLSK.
91.37% of the companies in the same industry are more expensive than CLSK, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.83, CLSK is valued a bit cheaper.
Industry RankSector Rank
PE 159.14
Fwd PE 12.09

4.2 Price Multiples

74.82% of the companies in the same industry are more expensive than CLSK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 30.44

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CLSK's earnings are expected to grow with 145.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y145.71%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CLSK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CLEANSPARK INC

NASDAQ:CLSK (12/20/2024, 8:02:44 PM)

After market: 11.2999 +0.16 (+1.44%)

11.14

+0.23 (+2.11%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)12-02 2024-12-02/amc
Earnings (Next)02-06 2025-02-06/amc
Inst Owners36.8%
Inst Owner Change4.94%
Ins Owners1.36%
Ins Owner Change62.24%
Market Cap3.26B
Analysts83.08
Price Target25.16 (125.85%)
Short Float %19.87%
Short Ratio1.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP-2.11%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)408.99%
Min EPS beat(2)-345.63%
Max EPS beat(2)1163.62%
EPS beat(4)2
Avg EPS beat(4)135.11%
Min EPS beat(4)-360.93%
Max EPS beat(4)1163.62%
EPS beat(8)5
Avg EPS beat(8)68.53%
EPS beat(12)5
Avg EPS beat(12)-1.64%
EPS beat(16)7
Avg EPS beat(16)26%
Revenue beat(2)1
Avg Revenue beat(2)-0.55%
Min Revenue beat(2)-7.95%
Max Revenue beat(2)6.85%
Revenue beat(4)2
Avg Revenue beat(4)-0.61%
Min Revenue beat(4)-7.95%
Max Revenue beat(4)6.85%
Revenue beat(8)3
Avg Revenue beat(8)-1.87%
Revenue beat(12)3
Avg Revenue beat(12)-5.05%
Revenue beat(16)3
Avg Revenue beat(16)-10.44%
PT rev (1m)0%
PT rev (3m)-3.65%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-100.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-550.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.29%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.96%
Valuation
Industry RankSector Rank
PE 159.14
Fwd PE 12.09
P/S 9.52
P/FCF N/A
P/OCF N/A
P/B 2.32
P/tB 2.34
EV/EBITDA 30.44
EPS(TTM)0.07
EY0.63%
EPS(NY)0.92
Fwd EY8.27%
FCF(TTM)-1.08
FCFYN/A
OCF(TTM)-0.67
OCFYN/A
SpS1.17
BVpS4.79
TBVpS4.75
PEG (NY)0.13
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.97%
ROE -11.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.45%
FCFM N/A
ROA(3y)-12.54%
ROA(5y)-50.73%
ROE(3y)-13.88%
ROE(5y)-64.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y28.38%
GM growth 5Y5.92%
F-Score5
Asset Turnover0.23
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0.01
Cap/Depr 76.06%
Cap/Sales 35.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.94
Quick Ratio 8.94
Altman-Z 26.24
F-Score5
WACC11.82%
ROIC/WACCN/A
Cap/Depr(3y)527.52%
Cap/Depr(5y)317.32%
Cap/Sales(3y)135.49%
Cap/Sales(5y)81.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.14%
EPS Next Y1215.8%
EPS Next 2Y145.71%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%69.99%
Revenue Next Year96.42%
Revenue Next 2Y37.04%
Revenue Next 3Y21.98%
Revenue Next 5YN/A
EBIT growth 1Y32.29%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year278.33%
EBIT Next 3Y73.12%
EBIT Next 5Y58.13%
FCF growth 1Y-418.71%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-492.83%
OCF growth 3YN/A
OCF growth 5YN/A